Navigation Links
Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
Date:5/10/2011

LAKE FOREST, Ill., May 10, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today held its 2011 Annual Meeting of Shareholders in Washington, D.C. The agenda included votes on seven items as well as an update on the company's progress in 2010 and its position going forward.

"2010 was a year marked with milestone achievements, but also scattered challenges," said F. Michael Ball, chief executive officer. "Through a keen focus on staying the course, we transformed obstacles into opportunities. In 2011, we continue to deliver on our strategy, remaining focused on propelling Hospira towards a future of sustainable top-ranking performance and increased value for our shareholders."

During the annual meeting, shareholders:

  • elected the following directors: Irving W. Bailey, II; F. Michael Ball; and Jacque J. Sokolov, M.D.; all Class I directors whose terms expire in 2014;
  • approved three amendments to Hospira's restated certificate of incorporation;
  • approved, by means of a shareholder advisory vote, the compensation of Hospira's named executive officers ("say on pay") as disclosed in the 2011 proxy statement;
  • determined, by means of a shareholder advisory vote, that the "say-on-pay" vote will occur every year; and
  • ratified the appointment of Deloitte & Touche LLP as Hospira's auditors for 2011.

A full description of the above matters is included in Hospira's proxy statement related to the meeting. The proxy statement is available on Hospira's website at www.hospirainvestor.com, as are Mr. Ball's remarks.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira Reports First-Quarter 2011 Results
2. Hospira Board Authorizes $1 Billion Share Repurchase Program
3. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
4. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
5. Hospira to Host Conference Call for First-Quarter 2011 Results
6. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
7. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
8. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
9. Hospira Announces U.S. Approval of Generic Docetaxel
10. Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
11. Hospira MedNet™ Portal Safety Software Benchmarking System Debuts at HIMSS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... The American Board of Family Medicine's (ABFM) Board of Directors has ... succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the ... at the end of 2018. Upon assuming the role of President and CEO on ...
(Date:10/13/2017)... ... , ... Apple Rehab Shelton Lakes , which specializes in the delivery ... as part of a disaster drill on October 3rd. , Apple Rehab participated with ... Manager, as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
Breaking Medicine News(10 mins):